Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety.
Zebrafish are becoming more widely used to study neurobehavioral pharmacology. We have developed a method to assess novel environment diving behavior of zebrafish as a model of stress response and anxiolytic drug effects. In a novel tank, zebrafish dwell in the bottom of the tank initially and then increase their swimming exploration to higher levels over time. We previously found that nicotine, which has anxiolytic effects in rodents and humans, significantly lessens the novel tank diving response in zebrafish. The specificity of the diving effect was validated with a novel vs. non-novel test tank. The novel tank diving response of zebrafish was tested when given three anxiolytic drugs from two different chemical and pharmacological classes: buspirone, chlordiazepoxide and diazepam. When the test tank was novel the diving response was clearly seen whereas it was significantly reduced when the test tank was not novel. Buspirone, a serotonergic (5HT(1A) receptor agonist) anxiolytic drug with some D(2) dopaminergic effect, had a pronounced anxiolytic-like effect in the zebrafish diving model at doses that did not have sedative effects. In contrast, chlordiazepoxide, a benzodiazepine anxiolytic drug, which is an effective agonist at GABA-A receptors, did not produce signs of anxiolysis in zebrafish over a broad dose range up to those that caused sedation. Diazepam another benzodiazepine anxiolytic drug did produce an anxiolytic effect at doses that did not cause sedation. The zebrafish novel tank diving task can be useful in discriminating anxiolytic drugs of several classes (serotonergic, benzodiazepines and nicotinic).
Bencan
Zachary
Z
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 340 Bell Building, Box 3412, Durham, NC 27710, USA.
Sledge
Damiyon
D
Levin
Edward D
ED
D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D001522:Behavior, Animal / Q000187:drug effects; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D002065:Buspirone / Q000008:administration & dosage / Q000627:therapeutic use*; D002707:Chlordiazepoxide / Q000008:administration & dosage / Q000627:therapeutic use*; D018678:Cholinergic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003975:Diazepam / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004242:Diving; D004305:Dose-Response Relationship, Drug; D005106:Exploratory Behavior / Q000187:drug effects; D021621:Imaging, Three-Dimensional / Q000379:methods; D018490:Serotonin Agents / Q000008:administration & dosage / Q000627:therapeutic use; D013315:Stress, Psychological; D013997:Time Factors; D015027:Zebrafish
D014151:Anti-Anxiety Agents; D018678:Cholinergic Agents; D018490:Serotonin Agents; D001569:Benzodiazepines; D002707:Chlordiazepoxide; D003975:Diazepam; D002065:Buspirone